Literature DB >> 2030943

A differentially expressed murine RNA encoding a protein with similarities to two types of nucleic acid binding motifs.

M Ayane1, U Preuss, G Köhler, P J Nielsen.   

Abstract

Using differential screening, a murine cDNA, termed X16, was isolated corresponding to an mRNA which is more strongly expressed in pre-B cell lines relative to mature B-cell lines. The complete coding sequence of the mRNA predicts a 19kD protein with two domains connected by a proline-rich spacer. The N-terminal domain of about 90 amino acids encodes an RNA binding motif including the ribonucleoprotein consensus octapeptide found in one class of RNA-binding proteins and highly conserved from yeast to man. Within the very basic C-terminal domain of about 60 amino acids, several copies of two different peptides are found which are also present in several proteins which bind DNA or RNA. The expression of X16 is not limited to the lymphoid lineage. In adult mice, although the strongest expression was seen in thymus, mRNA was also found in testis, brain, spleen, and very low in heart. X16 mRNA was not detected in liver and kidney. In tissue culture, the expression of X16 mRNA can be induced by serum. The conserved protein motifs and expression pattern suggest that X16 could be involved in RNA processing correlating with cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030943      PMCID: PMC333853          DOI: 10.1093/nar/19.6.1273

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Identification of macrophage-like characteristics in a cultured murine tumor line.

Authors:  H S Koren; B S Handwerger; J R Wunderlich
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

3.  DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

Authors:  S KIT; D R DUBBS; L J PIEKARSKI; T C HSU
Journal:  Exp Cell Res       Date:  1963-08       Impact factor: 3.905

4.  Murine B cell leukemia line with inducible surface immunoglobulin expression.

Authors:  C J Paige; P W Kincade; P Ralph
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

5.  Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin.

Authors:  P Ralph
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

6.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c.

Authors:  S M Hedrick; L A Matis; T T Hecht; L E Samelson; D L Longo; E Heber-Katz; R H Schwartz
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

8.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits.

Authors:  R Laskov; M D Scharff
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

View more
  35 in total

Review 1.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

2.  General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection.

Authors:  X D Fu; A Mayeda; T Maniatis; A R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

4.  A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon.

Authors:  M Vellard; A Sureau; J Soret; C Martinerie; B Perbal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  A mammalian germ cell-specific RNA-binding protein interacts with ubiquitously expressed proteins involved in splice site selection.

Authors:  D J Elliott; C F Bourgeois; A Klink; J Stévenin; H J Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Regulation of alternative polyadenylation by U1 snRNPs and SRp20.

Authors:  H Lou; K M Neugebauer; R F Gagel; S M Berget
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors.

Authors:  E Birney; S Kumar; A R Krainer
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

8.  Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.

Authors:  T D Levine; F Gao; P H King; L G Andrews; J D Keene
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Regulation of alternative splicing by SRrp86 and its interacting proteins.

Authors:  Jun Li; Ian C Hawkins; Christopher D Harvey; Jennifer L Jennings; Andrew J Link; James G Patton
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  Human SR proteins and isolation of a cDNA encoding SRp75.

Authors:  A M Zahler; K M Neugebauer; J A Stolk; M B Roth
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.